Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

NCT02621333 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
280
Enrollment
OTHER_GOV
Sponsor class

Stopped As there are so many clinical trials in progress and the number of patients enrolled limited.

Conditions

Interventions

Sponsor

Henan Cancer Hospital

Collaborators